Posts Tagged ‘Switzerland’
The Swiss Health Valley Region on One TV
Magali Bischof, BioAlps’ Secretary General is interviewed by Benjamin Smadja during the 13 World Chambers congress organised by CCIG Geneva. Watch the video from 18’00. ▶️ Video link
Read MoreSwiss and American researchers reached a potential milestone in cancer therapy
Researchers from the University of Bern, Inselspital, University Hospital Bern, and the University of Connecticut have made a significant breakthrough in the fight against cancer. They identified a previously unknown weak point of prostate cancer cells. This could also lead to entirely new therapeutic approaches for other types of cancer. Prostate cancer is the…
Read MoreLonza acquires Dutch biotech company Synaffix
The Valais-based pharmaceutical subcontractor will pay an initial €100 million, with subsequent milestone payments of up to a further €60 million. The deal will strengthen Lonza’s portfolio of antibody-drug conjugates (ADCs) through the integration of Synaffix’s platform. According to a recent estimate relayed by Lonza, the ADC market is set to pass the…
Read MoreArtiria receives FDA 510(k) Clearance for its deflectable guidewire for surgery
Artiria Medical, a Vaud-based neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by the U.S. Food and Drug Administration (FDA). This significant milestone opens a new pathway to a more advanced and effective approach to stroke treatment and related neurovascular and peripheral conditions. Artiria’s real-time…
Read MoreDistalmotion raises $ 150M
The fundraise, led by Revival Healthcare Capital, will be used to get a Food and Drug Administration (FDA) approval for Dexter, Distalmotion’s robotic surgery device. Dexter, Distalmotion’s robotic platform, is already in day-to-day clinical use in Europe, successfully treating patients across a multitude of complex and high-volume procedures in general surgery, gynecology, urology. This…
Read MoreErwin Böttinger is the new Wyss Center Geneva CEO
The Executive Board of the Wyss Center for Bio and Neuroengineering, a non-profit research center, is pleased to announce the appointment of Prof. Dr. med. Erwin Böttinger as its new Chief Executive Officer (CEO). Prof. Böttinger has a longstanding track record in personalized medicine, with emphasis on genomics and digital technologies. Before joining the…
Read MoreDebiopharm and Merck invest in artificial intelligence
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and M Ventures, the strategic, corporate venture capital arm of Merck, and Omnes Capital invested CHF 15.5 million in French startup Iktos By 2025, one in two drugs is expected to be discovered and developed using artificial intelligence. Iktos is a French…
Read MoreEFI-Lake Geneva Ventures and Yellowstone Holding AG invest CHF 3,5 million in Medyria
Medyria’s PyCath aims to be the only device on the market with pressure and blood flow velocity sensing for the invasive diagnosis of ischemic heart conditions. Medyria AG, is a Medtech company leader in blood flow velocity sensing. The start-up based in Winterthur recently launched the development of the PyCath a novel microcatheter for…
Read MoreThree Jura start-ups awarded with the DayOne Tech accelerator prize
The Jura branch of the Swiss Innovation Park Basel Area is home to 28 companies and institutions, including ten in Medtech. Three of them just received an innovation prize. “We have set up an acceleration and coaching programme with people from the industry who will accompany each of the start-ups,” explains Florian Sanner,…
Read MoreComphya receives approval for first pilot clinical trial in Australia
A swissmade neuromodulator to treat erectile dysfunction starts clinical trials in Australia Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), announced today that Australian regulatory authorities (Human Research Ethics Committees (HREC) and Therapeutic Goods Administration (TGA)) have approved the pilot clinical trial for CaverSTIM in patients undergoing prostatectomy. This will…
Read More